African Cannabis is a premier licensed producer of cannabis in Africa for medical applications, both for export markets and growing domestic markets. The company has already obtained its cultivation license in Lesotho.

African Cannabis aims to establish a globally recognised brand in production and export of quality, legally approved dried cannabis flower and cannabis oil products for medical uses.

African Cannabis intends to rapidly take advantage of growing global demand, the growing trend of legalisation across the African continent, and optimal production conditions in Africa.

In participating North American and European markets, the cost to produce medical cannabis is increasing, prompting buyers to seek premium cannabis from other legalized countries.

African Cannabis is the solution for global cannabis markets, being a premium licensed producer and exporter of high-quality medical cannabis, at lower costs.

With near-perfect growing conditions, lower costs of labour and operations, and many more benefits of cultivating cannabis in African countries, African Cannabis is leading the way in elevating Africa as a medical cannabis supplier to the world.

African Cannabis will produce and market dried cannabis flowers and cannabis oils of various tetrahydrocannabinol (THC) and cannabidiol (CBD) contents.

Africa

A Vast Opportunity Exists as Africa Catches Up on Legalisation.

More than 10,000 tons of cannabis are currently produced on the continent each year, according to the UN.

But African governments have not yet followed the trend of legalisation seen in Europe and the Americas, presenting a vast opportunity for developing legal production.

A few countries have begun the process of legalisation and offering licenses, including Lesotho, signalling a wider shift toward more liberal policies.

Several other African governments are considering tapping into what can be a lucrative natural resource for the continent.

  • Increasingly favourable legal and regulatory environment
  • Skilled agricultural labour
  • Lower labour costs
  • Ideal climate for cultivation
  • Rich soils
  • Essential infrastructure

Focus

African Cannabis Plans to Become a Major Cultivator and Global Exporter of GMP Medical Marijuana in Africa.

The company has already completed its licensing in Lesotho.

African Cannabis aims to establish a globally recognised brand in production and export of quality, legally approved dried cannabis flower and cannabis oil products for medical uses.

African Cannabis is growing rapidly amidst rising global demand, the trend towards legalisation across the African continent as well as optimal production conditions in Africa.

African Cannabis will produce and market dried cannabis flowers and cannabis oils of various tetrahydrocannabinol (THC) and cannabidiol (CBD) contents.

Medical marijuana

Global Opportunity

The Market for Medical Cannabis is Growing Rapidly, Driven by Rapid Legalisation and Increasing Medical Applications

Medical Cannabis Market, US$ billion

Source: Medical Marijuana Market Analysis 2017, Grand View Research
Source: Grand View Research, 2017, via Cannabis Business Executive (https://www.cannabisbusinessexecutive.com/2017/07/medical-marijuana-spreadingglobally-cancer-treatment-drive-growth/)

Rapid Global Pace of Legalisation is a Major Driver of Growth

Vast potential still exists, from further
legalisation, particularly in Asia and Africa.

  • North America accounts for over 49% of the market, with the U.S. being the single largest market.
  • In the U.S., the tax revenues of legal marijuana are now comparable with other commodities such as draft beer and e-cigarettes.
  • In the U.S., 28 states allow the sale of medical marijuana and out of these 7 states allow the sale of marijuana for both recreational and medical use.
  • In Europe, more than 10 countries now allow the sale of medical marijuana.
Source: Grand View Research, 2017, via Cannabis Business Executive (https://www.cannabisbusinessexecutive.com/2017/07/medical-marijuana-spreading-globally-cancer-treatment-drive-growth/); Legal Status of Medical Cannabis in the World, 2018, Wikipedia and Legal Status of Recreational Cannabis in the World, 2018, Wikipedia

Growing Medical Applications for Cannabis are also Fuelling Growth

Cannabis-derived compounds have been demonstrated in pre-clinical and clinical trials to be effective in the treatment of an increasing range of health conditions in humans.

Some of the therapeutic benefits of cannabinoids include Anti- inflammatory, Anti-convulsant, Anti-oxidant, Anti-emetic, Anxiolytic and Anti-psychotic.

As such, Medical Cannabis is now approved for treatment and/or the relief of symptoms in a wide range of conditions.

These include Anxiety/Stress Disorders, Metabolic Disorders/Diabetes, Neuro inflammation, Neurological Disorders/ Epilepsy, Oxidative injury, Nausea and Schizophrenia.

Some of the most important applications are Pain Management (in particular Chronic Pain) and Cancer.

Therapeutic benefits:
  • Anti-inflammatory
  • Anti-convulsant
  • Anti-oxidant
  • Anti-emetic
  • Anxiolytic
  • Anti-psychotic
Potential treatment of:
  • Anxiety/Stress Disorders
  • Metabolic Disorders/Diabetes
  • Neuro inflammation
  • Neurological Disorders/ Epilepsy
  • Oxidative injury
  • Nausea
  • Schizophrenia
  • Others
Source: Update of Cannabis and its medical use, WHO, 2015, Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb, Izzo et al. 2009, Medicinal Cannabis: History, Pharmacology, And Implications for the Acute Care Setting, 2017, Bridgeman and Abrazia; Most common qualifying conditions for medical marijuana, Leafly, 2018

EXECUTIVE TEAM

African Cannabis’ Board of Directors and Team is composed of thought-leaders from all over the world, working together from initial phases, to execution, to grow together as a global licenced producer supplying low-cost, high-quality medical cannabis.

ADVISORY BOARD

SCIENTIFIC ADVISORY BOARD

contact us

TORONTO OFFICE

African Cannabis Corp
99 Scollard Street
Toronto, ON
M5R 1G4
CANADA

All rights reserved 2018.